2017
DOI: 10.3899/jrheum.161273
|View full text |Cite
|
Sign up to set email alerts
|

Engaging Stakeholders and Promoting Uptake of OMERACT Core Outcome Instrument Sets

Abstract: The guidance provided in this paper is preliminary and is based on the views of the participants. Future work will engage OMERACT groups, "post-regulatory decision makers," and a broad range of different stakeholders to identify and evaluate the most useful methods and processes, and to revise guidance accordingly.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
18
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
7
1
1

Relationship

3
6

Authors

Journals

citations
Cited by 33 publications
(20 citation statements)
references
References 24 publications
2
18
0
Order By: Relevance
“…The implementation of core outcomes requires extensive stakeholder engagement, and specifically, end-users (eg, triallists who use them and clinicians who apply the results) need to be involved in the process of establishing core outcomes. 15 In recent studies, developers of core outcome sets have been interviewed to inform guidance for the conduct of core outcomes studies. 2 15 However, the perspectives of end-users on the concept, identification and expected impact of core outcomes remain largely unknown.…”
Section: Introductionmentioning
confidence: 99%
“…The implementation of core outcomes requires extensive stakeholder engagement, and specifically, end-users (eg, triallists who use them and clinicians who apply the results) need to be involved in the process of establishing core outcomes. 15 In recent studies, developers of core outcome sets have been interviewed to inform guidance for the conduct of core outcomes studies. 2 15 However, the perspectives of end-users on the concept, identification and expected impact of core outcomes remain largely unknown.…”
Section: Introductionmentioning
confidence: 99%
“…To ensure proper representation, inviting at least two PRPs is recommended [ 55 ]. Finally, acknowledgement of input and feedback to patients is essential, and integrated knowledge translation is desirable [ 56 ].…”
Section: Conclusion: Principles For Engaging With Patientsmentioning
confidence: 99%
“…The number of COS studies being published is increasing, but uptake of these cos in research has been variable. However, the importance of COS uptake has been acknowledged amongst key stakeholders including trialists [4], trial funders [5], clinical guideline developers [6], regulative authorities [7], payers [8] and industry [9]. Development of the COS-STAR (Core Outcome Set-STAndards for Reporting) guideline aims to improve the quality of reporting COS development studies [10].…”
Section: Introductionmentioning
confidence: 99%